Publikationer (relapsprojektet)

Peer-reviewed

Børty Nielsen L, Brøndum RF, Bøgsted M. ccostr: An R package for estimating mean costs with censored data. Journal of open source software. 2019 Sep 5. doi: 10.21105/joss.01593.

Bødker JS, Sønderkær M, Vesteghem C, Schmitz A, Brøndum RF, Sommer M, Rytter AS, Nielsen MM, Madsen J, Jensen P, Pedersen IS, Grubach L, Severinsen MT, Roug AS, El-Galaly TC, Dybkær K, Bøgsted M. Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark. Cancers (Basel). 2020 Jan 29;12(2). pii: E312. doi: 10.3390/cancers12020312. PubMed PMID: 32013121.

Nesic M, El-Galaly TC, Bøgsted M, Pedersen IS, Dybkær K. Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma. Expert Rev Hematol. 2020 Apr 15. doi: 10.1080/17474086.2020.1755958. [Epub ahead of print] PubMed PMID: 32293210.

Vesteghem C, Brøndum RF, Sønderkær M, Sommer M, Schmitz A, Bødker JS, Dybkær K, El-Galaly TC, Bøgsted M. Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives. Brief Bioinform. 2020 May 21;21(3):936-945. doi: 10.1093/bib/bbz044. PMID: 31263868; PMCID: PMC7299292

Sommer M, Nielsen LK, Nielsen LB, Brøndum RF, Nielsen MM, Rytter AS, Vesteghem C, Severinsen MT, El-Galaly TC, Bøgsted M, Grønkjær M, Jørgensen L. Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study. Health Qual Life Outcomes. 2021 Nov 4;19(1):251. doi: 10.1186/s12955-021-01887-6. PMID: 34736479; PMCID: PMC8567661.

Brøndum RF, Vestergaard AS, Børty L, Vesteghem C, Rytter AS, Nielsen MM, Severinsen MT, Jensen P, Gregersen H, El-Galaly TC, Dybkær K, Ehlers LH, Bøgsted M, Roug AS. Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system. Future Oncol. 2021 Sep;17(25):3331-3341. doi: 10.2217/fon-2021-0189. Epub 2021 Jun 22. PMID: 34156281.

Nesic M, Bødker JS, Terp SK, Dybkær K. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples. Biomed Res Int. 2021 Jul 8;2021:5585148. doi: 10.1155/2021/5585148. PMID: 34307658; PMCID: PMC8285169.

Nesic M, Sønderkær M, Brøndum RF, El-Galaly TC, Pedersen IS, Bøgsted M, Dybkær K. The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs. BMC Cancer. 2021 Jul 18;21(1):829. doi: 10.1186/s12885-021-08556-3. PMID: 34275438; PMCID: PMC8286604.

Vesteghem C, Dahl SC, Brøndum RF, Sønderkær M, Bødker JS, Schmitz A, Weischenfeldt J,Pedersen IS, Pedersen AS, Sommer M, Rytter AS, Nielsen MM, Ladekarl M, Severinsen MT, Dybkær K, Grønbæk K, El-Galaly TC, Roug AS, Bøgsted M. Implementing a data infrastructure for precision oncology projects leveraging REDCap Technical report, to be submitted.

Non peer-reviewed

Johnsen HE, Dybkær K, Bøgsted M, El-Galaly TC. Precision Medicine - Implementering af individualiseret behandling og vidensdatabase for hæmatologiske patienter med relaps. Best Practice, juli 2016.

Brøndum RF, Dybkær K, Bøgsted M. Realiseringen af personlig medicin i Danmark – hvad kræves der fra et bioinformatisk synspunkt? Best Practice, april 2017.

Bøgsted M, (red.), Führer A, Roug AS, Rytter AS, Vesteghem C, Høholt H, Ildal J, Dybkær K, Nielsen LB, Elkjær LT, Sønderkær M, Severinsen MT, Bøgsted M, Sommer M, Jensen P, Blindum PF, Brøndum RF, Dahl SC, El-Galaly TC. Aktivitetsrapport. Relapsprojektet 2015-2020: Personlig medicin ved hæmatologisk kræft. 1 udg. Aalborg Universitetshospital, 2021. 20 s.

Ph.d.-afhandlinger

Sommer M. Patient-reported outcomes on the trajectory of hematological cancer: A multi-method study. Aalborg Universitetsforlag, 2020. 97 s. (Aalborg Universitet. Det Sundhedsvidenskabelige Fakultet. Ph.D.-Serien).

Nesic M. The role of genetic alterations and immune surveillance in diffuse large B-cell lymphoma. Aalborg Universitetsforlag, 2021. 93 s. (Aalborg Universitet. Det Sundhedsvidenskabelige Fakultet. Ph.D.-Serien)